BERLIN (Reuters) – U.S. pharma company Eli Lilly plans to invest 2 billion euros ($2.17 billion) in a new plant in Alzey, western Germany, a source close to the negotiations told Reuters on Thursday.
Separately, people familiar with the plans told Reuters that at least 1,000 jobs would be created.
The company declined to comment.
Reuters had reported on Wednesday that the pharma group intended to invest in Germany after Eli Lilly called a news conference for Friday but few details were available.
($1 = 0.9217 euros)
(Reporting by Andreas Rinke and Rene Wagner; Writing by Madeline Chambers; Editing by Kirsti Knolle and Miranda Murray)
